Evaluation of the Anti-Adhesive Effect of Milk Fat Globule Membrane Glycoproteins on Helicobacter pylori in the Human NCI-N87 Cell Line and C57BL/6 Mouse Model

Helicobacter

Volumn 17, Issue 4, 2012, Pages 312-318

  Horemans, Tessa ^a   Kerstens, Monique ^a   Clais, Sofie ^a   Struijs, Karin ^b   Van den Abbeele, Pieter ^b   Van Assche, Tim ^a   Maes, Louis ^a   Cos, Paul ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Animal model; Antiadhesive therapy; Helicobacter pylori

Indexed keywords

GLYCOPROTEIN; MILK FAT GLOBULE MEMBRANE GLYCOPROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HELICOBACTER INFECTION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PLATE COUNT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BACTERIAL ADHESION; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; GASTRIC MUCOSA; GLYCOLIPIDS; GLYCOPROTEINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MICE; MICE, INBRED C57BL;

ANIMALIA; BACTERIA (MICROORGANISMS); HELICOBACTER; HELICOBACTER PYLORI;

EID: 84863606086     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2012.00948.x     Document Type: Article

References (33)

1. De Francesco V, Giorgio F, Hassan C, Manes G, Vannella L, Panella C, et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis 2010;19:409-14.
2. Kamiji MM, de Oliveira RB. Non-antibiotic therapies for Helicobacter pylori infection. Eur J Gastroenterol Hepatol 2005;17:973-81.
3. Liu KY, Shi Y, Luo P, Yu S, Chen L, Zhao Z, Mao XH, Guo G, Wu C, Zou QM. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. Vaccine 2011;29(38):6699-85.
4. Banerjee S, Medina-Fatimi A, Nichols R, Tendler D, Michetti M, Simon J, Kelly CP, Monath TP, Michetti P. Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers. Gut 2002;51:634-40.
5. Ryan KA, Daly P, Li Y, Hooton C, O'Toole PW. Strain-specific inhibition of Helicobacter pylori by Lactobacillus salivarius and other lactobacilli. J Antimicrob Chemother 2008;61:831-4.
6. Sezikli M, Cetinkaya ZA, Guzelbulut F, Yesil A, Cosgun S, Kurdas OO. Supplementing Vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori. J Clin Pharm Ther 2011. doi: (epub ahead of print).
7. Sheu BS, Yang HB, Yeh YC, Wu JJ. Helicobacter pylori colonization of the human gastric epithelium: a bug's first step is a novel target for us. J Gastroenterol Hepatol 2010;25:26-32.
8. Ofek I, Hasty DL, Sharon N. Anti-adhesion therapy of bacterial diseases: prospects and problems. FEMS Immunol Med Microbiol 2003;38:181-91.
9. O'Mahony R, Al-Khtheeri H, Weerasekera D, Fernando N, Vaira D, Holton J, Basset C. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol 2005;11:7499-507.
10. Lee JH, Park EK, Uhm CS, Chung MS, Kim KH. Inhibition of Helicobacter pylori adhesion to human gastric adenocarcinoma epithelial cells by acidic polysaccharides from Artemisia capillaris and Panax ginseng. Planta Med 2004;70:615-9.
11. Shmuely H, Burger O, Neeman I, Yahav J, Samra Z, Niv Y, Sharon N, Weiss E, Athamna A, Tabak M, Ofek I. Susceptibility of Helicobacter pylori isolates to the antiadhesion activity of a high-molecular-weight constituent of cranberry. Diagn Microbiol Infect Dis 2004;50:231-5.
12. Rasmussen JT. Bioactivity of milk fat globule membrane proteins. Aust J Dairy Technol 2009;64:63-7.
13. Heid HW, Keenan TW. Intracellular origin and secretion of milk fat globules. Eur J Cell Biol 2005;3:245-58.
14. Mather IH. A review and proposed nomenclature for major proteins of the milk-fat globule membrane. J Dairy Sci 2000;83:203-47.
15. Rombaut R, Dejonckheere V, Dewettinck K. Microfiltration of butter serum upon casein micelle destabilization. J Dairy Sci 2006;89:1915-25.
16. Wang X, Hirmo S, Willen R, Wadstrom T. Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BAlb/cA mouse model. J Med Microbiol 2001;50:430-5.
17. Linden SK, Sheng YH, Every AL, Miles KM, Skoog EC, Florin TH, Sutton P, McGuckin MA. MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog 2009;5:e1000617.
18. Gustafsson A, Hultberg A, Sjostrom R, Kacskovics I, Breimer ME, Boren T, Hammarstrom L, Holgersson J. Carbohydrate-dependent inhibition of Helicobacter pylori colonization using porcine milk. Glycobiology 2006;16:1-10.
19. Sun CQ, O'Connor CJ, Roberton AM. Antibacterial actions of fatty acids and monoglycerides against Helicobacter pylori. FEMS Immunol Med Microbiol 2003;36:9-17.
20. Wada T, Aiba Y, Shimizu K, Takagi A, Miwa T, Koga Y. The therapeutic effect of bovine lactoferrin in the host infected with Helicobacter pylori. Scand J Gastroenterol 1999;34:238-43.
21. Matsumoto M, Hara K, Kimata H, Benno Y, Shimamoto C. Exfoliation of Helicobacter pylori from gastric mucin by glycopolypeptides from buttermilk. J Dairy Sci 2005;88:49-54.
22. Stevens CR, Millar TM, Clinch JG, Kanczler JM, Bodamyali T, Blake DR. Antibacterial properties of xanthine oxidase in human milk. Lancet 2000;356:829-30.
23. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112:1386-97.
24. Park JG, Frucht H, LaRocca RV, Bliss DP Jr, Kurita Y, Chen TR, Henslee JG, Trepel JB, Jensen RT, Johnson BE. Characteristics of cell lines established from human gastric carcinoma. Cancer Res 1990;50:2773-80.
25. Le TT, Van CJ, Rombaut R, van LF, Dewettinck K. Effect of washing conditions on the recovery of milk fat globule membrane proteins during the isolation of milk fat globule membrane from milk. J Dairy Sci 2009;92:3592-603.
26. Clinical Institute and Laboratory Standards. Methods for the antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. 2nd Ed M45-A2 2006;30(18).
27. Van den Abbeele P, Grootaert C, Possemiers S, Verstraete W, Verbeken K, Van de Wiele T. In vitro model to study the modulation of the mucin-adhered bacterial community. Appl Microbiol Biotechnol 2009;83:349-59.
28. Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW. Prebiotic galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun 2006;74:6920-8.
29. Nishizawa T, Suzuki H, Nakagawa I, Minegishi Y, Masaoka T, Iwasaki E, Hibi T. Early Helicobacter pylori eradication restores sonic hedgehog expression in the gastric mucosa of Mongolian gerbils. Digestion 2009;79:99-108.
30. Yamazaki S, Kato S, Matsukura N, et al. Identification of Helicobacter pylori and the cagA genotype in gastric biopsies using highly sensitive real-time PCR as a new diagnostic tool. FEMS Immunol Med Microbiol 2005;44:261-8.
31. Okuda M, Nakazawa T, Yamauchi K, et al. Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: a randomized, double-blind, placebo-controlled study. J Infect Chemother 2005;11:265-9.
32. Huynh HQ, Campbell MA, Couper RT, Tran CD, Lawrence A, Butler RN. Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice. Lett Appl Microbiol 2009;48:517-22.
33. Mysore JV, Wigginton T, Simon PM, Zopf D, Heman-Ackah LM, Dubois A. Treatment of Helicobacter pylori infection in rhesus monkeys using a novel antiadhesion compound. Gastroenterology 1999;117:1316-25.